Author

M. A. Inlay

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Assay:ATAC-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

A. Anderson· 1 shared A. Mortazavi· 1 shared A. R. Najafi· 1 shared B. T. Dejene· 1 shared C. Lee· 1 shared C. Nicolas· 1 shared C. Sindhu· 1 shared D. X. Figueroa Velez· 1 shared

Activity by Year

2018-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Anderson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Subventricular zone/white matter microglia reconstitute the empty adult microglial niche in a dynamic wave

L. A. Hohsfield, A. R. Najafi, Y. Ghorbanian, N. Soni, J. Crapser, D. X. Figueroa Velez, S. Jiang, S. E. Royer, S. J. Kim, A. Anderson, S. P. Gandhi, A. Mortazavi, M. A. Inlay, K. N. Green

The paper depletes adult microglia using CSF1R inhibition and shows that subventricular zone/white matter myeloid cells dynamically repopulate the brain, exhibiting distinct phenotypes from endogenous microglia.

bioRxiv · Feb 17, 2021Immunology

Gene Correction for SCID-X1 in Long-Term Hematopoietic Stem Cells

M. Pavel-Dinu, V. Wiebking, B. T. Dejene, W. Srifa, S. Mantri, C. Nicolas, C. Lee, G. Bao, E. J. Kildebeck, N. Punjya, C. Sindhu, M. A. Inlay, N. Saxena, S. S. DeRavin, H. Malech, , M. Porteus

This study corrects SCID-X1 in hematopoietic stem cells using CRISPR/Cas9, achieving high integration frequencies and low off-target effects, supporting clinical development.

bioRxiv · Aug 22, 2018Bioengineering